The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I study of procaspase activating compound-1 (PAC-1) for treatment of advanced malignancies.
 
Oana C. Danciu
No Relationships to Disclose
 
Martin Kelly Nicholas
No Relationships to Disclose
 
Matthias Holdhoff
Consulting or Advisory Role - Abbvie; Celgene
Travel, Accommodations, Expenses - Arbor Pharmaceuticals
 
Richard A. Peterson
No Relationships to Disclose
 
Theodore M Tarasow
Employment - HealthTell; Systems Oncology; Vanquish Oncology
Leadership - Vanquish Oncology
Stock and Other Ownership Interests - HealthTell; Vanquish Oncology
Consulting or Advisory Role - Systems Oncology; Vanquish Oncology
Patents, Royalties, Other Intellectual Property - HealthTell; Vanquish Oncology
Travel, Accommodations, Expenses - HealthTell; Systems Oncology
 
Paul J. Hergenrother
Leadership - Vanquish Oncology
Stock and Other Ownership Interests - Vanquish Oncology
Consulting or Advisory Role - Vanquish Oncology
Research Funding - Vanquish Oncology
Patents, Royalties, Other Intellectual Property - Patents related to PAC-1
 
Arkadiusz Z. Dudek
Employment - Adhaere Pharmaceuticals
Leadership - IGF Oncology; Martell diagnostic
Stock and Other Ownership Interests - Biothera; IGF Oncology; Vanquish Oncology
Honoraria - Biothera; IGF Oncology; Medtronic; Vanquish Oncology
Consulting or Advisory Role - Biothera; TTC Oncology; Vanquish Oncology